⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NXTC News
NextCure, Inc. Common Stock
NextCure and Simcere’s SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026
globenewswire.com
NXTC
NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer
globenewswire.com
NXTC
NextCure and Simcere’s SIM0505 (CDH6 ADC) Abstract Accepted for ASCO 2026
globenewswire.com
NXTC
Form 8-K
sec.gov
NXTC
NextCure Provides Business Update and Reports Full Year 2025 Financial Results
globenewswire.com
NXTC
NextCure Provides Business Update
globenewswire.com
NXTC
NextCure to Present at the Piper Sandler 37th Annual Healthcare Conference
globenewswire.com
NXTC
NextCure Announces Closing of $21.5 Million PIPE Financing in Advance of First Half 2026 Phase 1 POC Data Readouts
globenewswire.com
NXTC
NextCure Announces $21.5 Million Private Placement of Common Stock Priced at the Market Under Nasdaq Rules
globenewswire.com
NXTC
NextCure Provides Business Update and Reports Third Quarter 2025 Financial Results
globenewswire.com
NXTC